Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Abbott researchers found a high proportion of elite HIV controllers in the Democratic Republic of Congo, which could lead to cure insights.
Genetic sequencing indicated that three samples from 1983 to 2001 were all part of a newly established subtype L of group M of the virus.
Gloria Searson has been fighting to end the epidemic in New York City for almost 25 years.
ViiV Healthcare, an HIV company formed by Pfizer and GlaxoSmithKline, has established a pharmaceutical manufacturing partnership with Russian...
A federal jury in California has told Abbott Laboratories to pay GlaxoSmithKline $3.5 million in damages for breach of agreement, but...
The U.S. Food and Drug Administration has approved Abbott Laboratories’ new HIV test, which can detect HIV types 1 and 2.
The AIDS Treatment Activists Coalition has issued its first report card grading nine major pharmaceutical companies on their efforts to combat...
On September 10, the AIDS Treatment Activists Coalition (ATAC) released a report card on the pharmaceutical industry that graded nine pharmace...
A major clinical trial demonstrated that Prezista plus Norvir is more effective than Kaletra in treatment-experienced HIV-positive patients.
Abbott Laboratories is reportedly offering a Kaletra (lopinavir/ritonavir) price cut to the Thai government
New recommendations to routinely test most Americans for HIV is expected to be profitable for Abbott Laboratories and OraSure Technologies
In early May, the FDA approved once-daily dosing of Abbott’s powerhouse protease inhibitor (PI) Kaletra (lopinavir plus booster ritonavir)..
How to stomach liquid Norvir
Abbott’s manufacturing malady is hard to swallow
The first of the new antiviral drugs revives difficult dilemmas about research versus access
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.